mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-05 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |